Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.
Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a broad list of trial locations across the United States, Australia, Canada, and New Zealand, and updated the study status to Completed. These changes reflect the open-label extension and expanded site participation.SummaryDifference2%
- Check50 days agoChange DetectedRevision: v3.3.2 is displayed on the page, replacing v3.2.0.SummaryDifference0.0%
- Check58 days agoChange DetectedRemoved the government-funding notice warning that information may not be up to date, removing the explicit caveat about updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check72 days agoChange DetectedDifference0.3%
- Check101 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference4%
Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.